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17β-estradiol Changes the Human Cerebral Endothelial Cell Proteome Upon 
Exposure to Cyclic Stretch
(17β-estradiol Merubah Proteome Sel Endotelial Serebral Manusia yang Terdedah Kepada Regangan)
NURUl FaRHaNa JUFRi, abidali MoHaMEdali, SEoNg bEoM aHN, albERTo avolio & MaRK S. baKER
abSTRaCT
Hypertension and estrogen deficiency in women have been identified as significant risk factors for cerebrovascular 
diseases. Hypertension causes excessive vascular stretch and contributes to the initiation of cellular injury in blood 
vessels while estrogen has been demonstrated to exert beneficial protective effects on the vascular system. Although the 
specific biological outcomes exerted by either excessive stretch or estrogen exposure are well established, the combined 
biochemical effects of both stimuli remain unclear. Therefore, this study was conducted for quantitative proteomics study 
on human cerebral microvascular endothelial cells (HCMECs) subjected to 20% “pathological” cyclic stretch for a 
period of 18 hour in the presence or absence of 17β-estradiol by isobaric Taqs for Relative and Absolute Quantification. 
The results showed that only some proteins responded to 17β-estradiol (e.g., thioredoxin reductase-1), stretch (e.g., 14-
3-3 protein epsilon or acidic leucine-rich nuclear phosphoprotein 32 family member B) and interestingly, some proteins 
returned to control pre-treatment levels when exposed to both (e.g., d-dopachrome decarboxylase, thrombospondin-1). In 
addition, HCMECs that exposed only to estrogen had a very similar proteomic profile (i.e., up-regulation of structural, 
cellular adhesion and proliferation proteins) as to those exposed to estrogen with 20% stretching for 18 hour, suggesting 
that estrogen ablated the detrimental effects by the stretch alone. These findings sheds light on the molecular mechanisms 
by which the cerebrovascular protective actions of estrogen on HCMEC exposed to pathological levels of cyclic stretch 
which could provide a platform for future research in therapeutic approach. 
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abSTRaK
Tekanan darah tinggi dan kekurangan estrogen di kalangan wanita telah dikenal pasti sebagai faktor risiko penyakit 
serobrovaskular. Tekanan darah tinggi menyebabkan regangan salur darah berlebihan dan membawa kepada kecederaan 
sel salur darah. Estrogen telah menunjukkan kesan perlindungan pada sistem vaskular. Walaupun kesan spesifik biologi 
yang dihasilkan oleh regangan dan estrogen diketahui, kesan kombinasi kedua-dua stimuli ini masih tidak jelas. Justeru, 
kajian kuantitatif proteomik ini dilakukan pada sel endotelium serebral manusia pada 20% regangan patologi selama 
18 jam dengan atau tanpa kehadiran 17β-estradiol. Sesetengah protein hanya bertindak balas kepada 17β-estradiol 
(thioredoxin reduktase-1); hanya kepada regangan (14-3-3 protein epsilon atau asid kaya-leusin- nuklear fosfoprotein 32 
kumpulan B) dan protein yang kembali ke paras asal (d-dopakrom dekarboksilase, thrombospondin-1). Sel yang terdedah 
kepada 17β-estradiol mempunyai profil proteomik yang sama dengan pendedahan 17β-estradiol dan regangan patologi. 
Ini menunjukkan estrogen boleh menahan kesan yang dikaitkan dengan regangan patologi. Kajian ini memberikan 
gambaran mekanisme molecular perlindungan serebrovaskular terhadap estrogen pada sel yang terdedah kepada 
regangan patologi yang boleh digunakan untuk kajian masa depan dalam pendekatan teraputik.
Kata kunci: Regangan berulang; estrogen; aneurisma intrakranial; ekspresi proteomik; sel vaskular endotelial
iNTRodUCTioN
intracranial aneurysm (ia) is the dilatation of a cerebral 
artery segment due to fragility in the arterial wall that 
usually arised at the bifurcation regions of Circle of Willis. 
it is often small in size and asymptomatic, however, it can 
be fatal when it ruptures which lead to bleeding, resulting 
in subarachnoid haemorrhage (SaH) (Keedy 2006). about 
2-3% of the general population of the world developed ia 
(Juvela 2011; Rinkel et al. 1998). in addition, 5-15% of 
strokes are related to ruptured ia which are often classified 
as hemorrhagic stroke (bederson et al. 2000). Several risk 
factors have been associated with ia such as hypertension, 
gender, family history, alcohol consumption and smoking 
(Cebral & Raschi 2000; Rinkel 2005).
a causal link between hypertension and aneurysms has 
been established, with previous studies showing it to be as 
high as 44% compared to normotensive individuals (24%) 
(inci & Spetzler 2000). interestingly, both hypertension 
and aneurysm share similar risk factors, that may indicate 
their close pathogenic relationship (Chen et al. 2015; Wei 
et al. 2015). Hypertension exerts excessive hemodynamic 
pressure on vascular walls. The increase in chronic pulsatile 
pressure could lead to overstretching of the vessels that 
Chap 9.indd   55 31/05/2018   15:28:12
56
in turn may lead to cellular injury and eventually cause 
vascular weakness, endothelial dysfunction, scarring and 
an increased tendency for aneurysm formation in arteries 
(anwar et al. 2012, Pascarella et al. 2008, Thubrikar 
& Robicsek 1995). one significant observation is that 
postmenopausal women have been reported to have high 
prevalence of ia and SaH compared to premenopausal 
women, and this has been shown to be due to low levels 
of estrogen (longstreth et al. 1994). it has therefore been 
proposed that the risk of cerebrovascular disease rises as 
endogenous estrogen levels decline due to ageing and 
menopause in women.
To investigate proteins that are modulated, in cells 
of hypertension-induced stretch, an in-vitro approach has 
been developed where pathological cyclic stretch at 20% 
amplitude was applied (anwar et al. 2012). a previous 
study has shown that pathological stretch can induce cell 
proliferation, apoptosis, production of reactive oxygen 
species (RoS) and inflammation which can contribute to 
cardiovascular diseases (anwar et al. 2012). it is clear that 
the in vitro pathological cyclic stretch model is useful for 
understanding the range of pathophysiological biochemical 
and molecular changes occurring as a result of stretch in 
specific cell types allowing the study of factors such as 
estrogen exposure or drug exposure to be carried out. 
Mechanical stretch on endothelial cells is associated 
with many negative effects and understanding how these 
negative effects can be mitigated using estrogen will 
be a therapeutic value (anwar et al. 2012). This study 
aimed to investigate the concurrent effects of both stimuli 
(stretch and estrogen) on human cerebral microvascular 
endothelial cells (HCMEC). although a number of stretch 
studies have been conducted on smooth muscle cells, 
this is the first study of its kind on cerebellar endothelial 
cells whose its biology is implicated in ia and SaH. We 
employed an approach using isobaric Taqs for Relative and 
absolute Quantification (iTRaQ), 4-plex label quantitative 
proteomics approach on HCMECs that were subjected to 
physiological concentrations of 17β-estradiol at 20% cyclic 
stretch intensity separately and simultaneously for 18 hour 
to simulate chronic hypertension to allow a detailed view 
of the global changes occurring on these cells.
METHodS
CEll liNES
HCMECs (abM, Richmond, Canada) at low passage were 
cultured on fibronectin-coated (20 µg/ml) silicone cubes 
in M199 media supplemented with 10% fetal bovine 
serum (FbS) at 37°C (5% Co2). Fibronectin was selected 
as the coating material as the cells could attach well on 
the silicone cube. Upon reaching 70% confluence, the 
media was replaced with M199 phenol red free media 
supplemented with 10% charcoal-stripped FbS to prevent 
any inadvertent steroid hormone activity. Each experiment 
was conducted for the 4 groups at 37°C (5% Co2); no 
stretch nor 17β-estradiol as a control (C); cells exposed 
to 1 nM 17β-estradiol (E), cells exposed to 20% stretch 
(S) and cells exposed to both stimuli (E + S). The media 
in each group was changed and the 17β-estradiol was 
added into the media for group (E) and (E + S) prior to 
the experiment.
MECHaNiCal STRETCH oN HCMEC
Cells grown on silicone cubes were subjected to cyclic 
mechanical stretch using the Shellpa Mechanical Cell 
Stretch System (Menicon life Science, Japan). in detail, 
uniaxial strain was applied to the cells by a vacuum pump 
programmed at 60 cycle/min at a 20% stretch magnitude 
for 18 hour. The control cells were grown in the same 
condition and placed in the same incubator without being 
subjected to stretch.
iTRaQ FoUR PlEx labEliNg
isobaric Tag for Relative and absolute Quantification 
(iTRaQ) kit (abSciex, Framingham, USa) was used for 
protein labeling based on the manufacturer’s instructions. 
The protein concentration was determined using bCa protein 
assay kit (Thermo Scientific, Rockford, USa). briefly, 100 
µg of protein from each condition was reduced with 50 mM 
methanethiosulfonate for 1 hour, followed by alkylation 
using 200 mM iodoacetamide for 30 minute. Proteins were 
then digested with trypsin at a ratio of 1:25 and incubated 
at 37°C overnight. The samples were dried in Centrivap 
Complete vacuum concentrator (labconco, Kansas, United 
States). Each iTRaQ tag was then added to the sample and 
incubated for 1 hour at room temperature. after labelling, 1 
µl from each iTRaQ label was pooled in a new tube. The 
pooled sample was ZipTip-purified (Millipore) and spotted 
onto a matrix-assisted laser desorption/ionization (Maldi) 
plate with matrix (2,5-dihydroxy benzoic acid-dHb). The 
sample was first run under Maldi tandem time of flight 
(ToF/ToF) to ensure that iTRaQ reactions were successful. 
all samples were then pooled in new tubes and dried.
STRoNg CaTioN ExCHaNgE HigH PERFoRMaNCE liQUid 
CHRoMaTogRaPHy
dried iTRaQ labeled samples were resuspended in loading 
buffer a (5 mM phosphate 25% acetonitrile, pH 2.7). 
after sample loading and washing the column (PolylC 
polysulfoethyl a column 200 × 2.1 mm) with buffer a, 
buffer b (5 mM phosphate, 350 mM potassium chloride, 
25% acetonitrile, pH 2.7) concentration was increased 
from 10% to 45% across a 70 minute gradient and then 
increased quickly to 100%. The buffer was held at 100% 
for 10 minute with a flow rate of 300 µl/minute. The 
eluent of strong cation exchange high performance liquid 
chromatography (SCx HPlC) was collected every 2 minute 
from the beginning of the gradient and at 4 minute intervals. 
Collected fractions were dried in vacuum centrifugation.
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NaNolC ESi MS/MS daTa aCQUiSiTioN
a total of 11 fractions were isolated from SCx HPlC. Each 
fraction was resuspended in 60 µl of loading/desalting 
solution (0.1% formic acid and 2% acetonitrile in water). 
The samples were analyzed by Triple ToF 5600 (abSciex, 
Massachusetts, United States). Samples (40 µl) were 
injected into a peptide trap (Michrome Peptide Captrap) 
column for pre-concentration and desalting with 0.1% 
formic acid, 2% acetonitrile at 10 µl/min for 5 min. The 
peptide trap was then switched on line with an analytical 
column. Peptides were eluted from the column using a 
linear solvent gradient, from mobile phase a (0.1% formic 
acid): mobile phase b (90% acetonitrile/0.1% formic acid) 
(98:2) to mobile phase a: mobile phase b (65:40) at 550 
nl/minute over 100 minute period. after peptide elution, 
the column was cleaned with 95% buffer b for 15 minute 
and then equilibrated with buffer a for 25 min before next 
sample injection.
The reverse phase nanolC eluent was subjected to 
positive ion nanoflow electrospray ionization (ESi) analysis 
in an information-dependent acquisition mode (ida). a 
ToF electrospray mass spectrometry (MS) survey scan 
was acquired (m/z 400-1500, 0.25 second), with the ten 
most intense multiply charged ions (counts > 150) in the 
survey scan sequentially subjected to MS/MS analysis. MS/
MS spectra were accumulated for 200 ms in the mass range 
m/z 100-1500 with the total cycle time of 2.3 seconds.
daTa PRoCESSiNg
The experimental nanolC ESi MS/MS data were submitted 
to ProteinPilot v4.2b (ab Sciex) for data processing 
searching against the SwissProt 2014_04 Human database. 
The results were analysed using combined p-value analysis 
(Pascovici et al 2015). a protein is considered to be 
differentially expressed if the Stouffer p-value is less than 
0.05 and all protein ratios in duplicate are in similar trend 
(both are up-regulated or down-regulated).  To functionally 
annotate the proteins based on their biological processes, 
the up and down-regulated proteins were subjected to gene 
ontology annotation using Plogo (Pascovici et al 2012). 
RESUlTS aNd diSCUSSioN
a total of 2,772 proteins were identified in all samples 
with a protein false discovery rate (FdR) of < 1%. out of 
this, 137 proteins were identified as being significantly 
and differentially expressed (p < 0.05) when cutoff ratios 
were arbitrarily applied between < 0.82 and > 1.2 with 
respect to controls listed in Table 1. gene ontology (go) 
analysis using Plogo was conducted on all proteins that 
changed significantly (P ≤ 0.05) in E, S and E + S groups 
to gain a clearer understanding of protein function and 
possible implications. Exposure to 17β-estradiol (i.e., 
the E group) of HCMEC up-regulated proteins involved 
in cell processes such as cell proliferation, cell adhesion, 
and structural molecule activity (Table 2). However, the 
S group demonstrated different protein profiles as several 
proteins were not significantly changed in comparison to 
E group. These included proteins that were involved in 
cell proliferation [catenin β-1 (CTNNb1) and thioredoxin 
reductase 1 (TxNRd1)], cell adhesion [alpha-actinin-1 
(aCTN1), integrin alpha-3 (iTga3), alpha-parvin (PaRva)] 
and structural molecule activity [actin-related protein 2 
(aCTR2)]. The proteins then were analyzed based on its 
trends at each group conditions (Figure 1).
TablE 1. list of significantly different proteins (p < 0.05) against normal with a cutoff ratio > 1.2 and < 0.82 against the control. 
The proteins were grouped based on trends observed in the experiment; trend i: protein upregulated in E and E + S; trend  
ii: proteins downregulated in E and E + S; trend iii: proteins upregulated in S and E + S; trend iv: proteins downregulated in S and 
E + S; trend v: protein downregulated in E and upregulated in S, trend vi: proteins upregulated in E and downregulated in S; trend 
vii: proteins downregulated in E, upregulated in S and downregulated in E + S; and other proteins that were not included the trend. 
The red colour indicates the up-regulated proteins, the green colour indicates down-regulated protein and other indicates proteins 
that did not change.
         
Protein gene
 Estrogen only Stretch only Stretch and
   (E) (S) estrogen (E + S)
Trend i
 aTP synthase subunit alpha aTP5a1 1.23 0.98 1.23
 Catenin beta-1 CTNNb1 1.24 1.06 1.24
 importin-5 iPo5 1.24 0.98 1.20
 dolichyl-diphosphooligosaccharide—protein RPN2 1.26 1.08 1.24
  glycosyltransferase subunit 2
 Probable aTP-dependent RNa helicase ddx5 1.29 1.12 1.38
 actin-related protein 2 aCTR2 1.29 0.93 1.24
 Switch-associated protein 70 SWaP70 1.36 1.10 1.39
 alpha-actinin-1 aCTN1 1.36 1.16 1.33
 isochorismatase domain-containing protein 1 iSoC1 1.45 1.19 1.25
 Keratin, type i cytoskeletal 10 KRT10 1.46 0.83 1.45
Continued
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TablE 1. Continue
         
Protein gene
 Estrogen only Stretch only Stretch and
   (E) (S) estrogen (E + S)
 glucose-6-phosphate isomerase gPi 1.47 0.91 1.23
 Phospholipase d3 Pld3 1.48 0.89 1.46
 integrin alpha-3 iTga3 1.50 1.18 1.43
 Thioredoxin reductase 1, cytoplasmic TxNRd1 1.55 1.18 1.44
 Transketolase TKT 1.59 1.16 1.33
 Transgelin TaglN 1.74 1.17 1.23
Trend ii
 dynamin-2 dNM2 0.60 0.86 0.70
 Cyclin-dependent kinase 1 CdK1 0.71 1.15 0.80
 Heterogeneous nuclear ribonucleoprotein a3 HNRNPa3 0.73 0.84 0.72
 vigilin HdlbP 0.75 0.83 0.76
 alpha-parvin PaRva 0.76 0.91 0.72
 Transforming acidic coiled-coil-containing protein 1 TaCC1 0.79 1.01 0.79
 Rho gTPase-activating protein 17 aRHgaP17 0.79 1.09 0.71
 Cytoplasmic dynein 1 intermediate chain 2 dyNC1i2 0.80 0.87 0.83
 Heterogeneous nuclear ribonucleoprotein M HNRNPM 0.81 0.91 0.78
Trend iii
 Transcription initiation factor iib gTF2b 0.99 1.72 1.27
 Protein bicaudal d homolog 2 biCd2 1.04 1.36 1.45
 Transmembrane 9 superfamily member 4 TM9SF4 1.06 1.48 1.40
 Pyruvate dehydrogenase E1 component PdHa1 1.06 1.37 1.36
  subunit alpha, somatic form, mitochondrial 
 Retinal dehydrogenase 2 aldH1a2 1.11 1.42 1.35
 Nuclear pore complex protein Nup93 NUP93 1.14 1.32 1.28
 Serine/arginine repetitive matrix protein 2 SRRM2 1.16 1.31 1.20
Trend iv
 Signal transducer and activator of transcription  STaT1 0.84 0.75 0.68
  1-alpha/beta 
 Serine hydroxymethyltransferase, mitochondrial SHMT2 0.85 0.55 0.69
 x-ray repair cross-complementing protein 6 xRCC6 0.86 0.73 0.80
 Cytoplasmic dynein 1 heavy chain 1 dyNC1H1 0.87 0.79 0.81
 14-3-3 protein epsilon yWHaE 0.87 0.79 0.75
 acidic leucine-rich nuclear phosphoprotein aNP32b 0.93 0.59 0.66
  32 family member b 
 Citrate synthase, mitochondrial CS 0.95 0.78 0.77
 gTP-binding nuclear protein Ran RaN 1.11 0.70 0.67
 Trend v
 d-dopachrome decarboxylase ddT 0.66 1.93 1.06
Trend vi
 Thrombospondin-1 THbS1 1.30 0.75 0.95
 aTP synthase subunit beta, mitochondrial aTP5b 1.37 0.68 0.97
 Trend vii
 Protein FaM49b FaM49b 0.73 1.22 0.78
Continued
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TablE 1. Continue
         
Protein gene
 Estrogen only Stretch only Stretch and
   (E) (S) estrogen (E + S)
 other Proteins
 interferon-induced gTP-binding protein Mx1 Mx1 0.20 0.43 0.28
 Septin-11 SEPT11 0.22 0.17 0.20
 Septin-9 SEPT9 0.33 0.52 0.39
 Septin-2 SEPT2 0.47 0.56 0.52
 Septin-7 SEPT7 0.47 0.64 0.53
 Retinal dehydrogenase 1 aldH1a1 0.50 0.51 0.51
 Unconventional myosin-ic Myo1C 0.57 0.59 0.65
 lamina-associated polypeptide 2, isoform alpha TMPo 0.59 0.80 0.67
 Prelamin-a/C lMNa 0.59 0.57 0.53
 dNa-dependent protein kinase catalytic subunit PRKdC 0.62 0.65 0.61
 Caveolin-1 Cav1 0.64 0.66 0.62
 Elongation factor 1-gamma EEF1g 0.65 0.67 0.64
 very long-chain specific acyl-Coa dehydrogenase,  aCadvl 0.71 0.75 0.71
  mitochondrial 
 Mesencephalic astrocyte-derived neurotrophic factor MaNF 0.74 0.77 0.75
 Heterogeneous nuclear ribonucleoprotein a1 HNRNPa1 0.75 0.77 0.69
 Protein FaM98b FaM98b 0.77 0.65 0.79
 Protein-glutamine gamma-glutamyltransferase 2 TgM2 0.81 0.67 0.66
 acyl-coenzyme a thioesterase 9, mitochondrial aCoT9 0.83 1.03 1.04
 Trifunctional enzyme subunit alpha, mitochondrial HadHa 0.85 0.93 0.92
 Spectrin alpha chain, non-erythrocytic 1 SPTaN1 0.88 0.94 0.88
 Staphylococcal nuclease domain-containing protein 1 SNd1 0.88 1.13 0.99
 Translational activator gCN1 gCN1l1 0.90 1.06 0.86
 26S proteasome non-aTPase regulatory subunit 1 PSMd1 0.90 0.99 0.96
 Cytoplasmic aconitate hydratase aCo1 0.94 0.98 0.99
 Ubiquitin-like modifier-activating enzyme 1 Uba1 0.95 0.94 1.02
 Filamin-a FlNa 1.01 0.88 0.89
 Rho gTPase-activating protein 18 aRHgaP18 1.02 0.99 1.05
 dNa replication licensing factor MCM5 1.03 0.92 1.05
 U5 small nuclear ribonucleoprotein 200 kda helicase SNRNP200 1.06 1.06 1.01
 Neuroblast differentiation-associated protein aHNaK 1.07 1.10 0.91
 CoP9 signalosome complex subunit 4 CoPS4 1.14 0.91 1.08
 Endoglin ENg 1.19 0.89 0.95
 band 4.1-like protein 3 EPb41l3 1.20 0.97 1.19
 Palmdelphin PalMd 1.20 1.62 1.35
 Protein-lysine 6-oxidase lox 1.22 1.70 1.51
 Calpain-2 catalytic subunit CaPN2 1.27 1.27 1.52
 Extended synaptotagmin-1 ESyT1 1.27 1.23 1.23
 liM domain only protein 7 lMo7 1.29 1.60 1.35
 Membrane-associated progesterone receptor component 2 PgRMC2 1.35 1.21 1.74
 aldehyde dehydrogenase family 1 member a3 aldH1a3 1.35 1.59 1.41
 Serine palmitoyltransferase 2 SPTlC2 1.36 1.36 1.55
 Cell surface glycoprotein MUC18 MCaM 1.37 1.33 1.40
 guanine nucleotide-binding protein g(s) gNaS 1.38 1.23 1.38
  subunit alpha isoforms xlas 
 Cadherin-2 CdH2 1.38 1.25 1.59
 UdP-N-acetylhexosamine pyrophosphorylase UaP1 1.39 1.34 1.39 
 glutathione S-transferase Mu 3 gSTM3 1.41 1.21 1.60
Continued
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TablE 1. Continue
         
Protein gene
 Estrogen only Stretch only Stretch and
   (E) (S) estrogen (E + S)
 E3 ubiquitin-protein ligase HECTd1 1.41 1.55 1.58
 acylamino-acid-releasing enzyme aPEH 1.42 1.25 1.42
 bTb/PoZ domain-containing protein KCTd12 1.43 1.37 1.39
 Fibronectin FN1 1.43 2.11 1.43
 Prostaglandin reductase 1 PTgR1 1.43 1.59 1.53
 4F2 cell-surface antigen heavy chain SlC3a2 1.47 1.44 1.57
 Heat shock 70 kda protein 1a/1b HSPa1a 1.59 1.45 1.66
 Ferritin light chain FTl 1.59 1.68 1.70
 lysosome-associated membrane glycoprotein 1 laMP1 1.82 1.27 1.67
 annexin a2 aNxa2 1.86 1.85 1.49
 annexin a6 aNxa6 2.11 1.54 1.74
 Heme oxygenase 1 HMox1 2.63 2.27 2.50
 apolipoprotein E aPoE 6.72 1.66 3.78
 Peptidyl-prolyl cis-trans isomerase FKbP3 0.63 0.76 0.86
 Serpin b9 SERPiNb9 0.79 0.80 0.85
 Structural maintenance of chromosomes protein 4 SMC4 0.72 0.85 1.05
 aP-2 complex subunit mu aP2M1 0.76 1.01 1.02
 Phenylalanine--tRNa ligase alpha subunit FaRSa 0.76 0.96 0.93
 Structural maintenance of chromosomes protein 2 SMC2 0.78 0.97 0.90
 Phenylalanine--tRNa ligase beta subunit FaRSb 0.83 1.00 0.89
 PRKC apoptosis WT1 regulator protein PaWR 0.83 1.08 0.89
 Protein dJ-1 PaRK7 0.83 0.83 0.84
 Prefoldin subunit 3 vbP1 0.95 0.66 0.83
 Kinesin-1 heavy chain KiF5b 0.97 0.80 0.83
 Purine nucleoside phosphorylase PNP 1.10 0.79 1.07
 Peroxiredoxin-6 PRdx6 1.11 0.81 0.93
 Tryptophan--tRNa ligase, cytoplasmic WaRS 0.84 0.86 0.71 
 Keratin, type ii cytoskeletal 8 KRT8 0.87 0.86 0.66
 Heterogeneous nuclear ribonucleoprotein K HNRNPK 0.92 0.89 0.78
 Myosin-9 MyH9 0.94 0.97 0.78
 Na(+)/H(+) exchange regulatory cofactor NHE-RF1 SlC9a3R1 1.00 1.25 0.85
 Ribosome-binding protein 1 RRbP1 1.09 1.29 1.06
 aconitate hydratase, mitochondrial aCo2 1.04 0.93 1.33
 acetyl-Coa carboxylase 1 aCaCa 1.07 0.98 1.30
 Elongation factor Tu, mitochondrial TUFM 1.14 1.03 1.42
 arginine--tRNa ligase, cytoplasmic RaRS 1.16 0.88 1.34
 Keratin, type i cytoskeletal 18 KRT18 1.20 1.22 0.81
 116 kda U5 small nuclear ribonucleoprotein component EFTUd2 1.21 1.04 1.09
 Poly(U)-binding-splicing factor PUF60 1.22 1.03 1.14
 Fatty acid synthase FaSN 1.22 1.10 1.20
 N-acetyl-d-glucosamine kinase NagK 1.26 1.08 1.19
 Filamin-C FlNC 1.33 1.13 1.08
 Nucleosome assembly protein 1-like 4 NaP1l4 1.34 0.95 1.14
 Calreticulin CalR 1.56 0.87 1.10
 Caldesmon Cald1 1.24 1.32 0.99
 Plectin PlEC 1.27 1.22 1.19
 Keratin, type ii cytoskeletal 1 KRT1 1.40 0.77 1.34
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TablE 2. list of proteins expressed in HCMEC subjected to 17β-estradiol, 20% stretch and both stimuli based on gene ontology 
Plogo analysis. only proteins that has similar regulations between estrogen only group (E) and estrogen + stretch (E + S) were 
selected. The red colour indicates the up-regulated proteins, the green colour indicates down-regulated protein and other indicates 
proteins that did not change.
 
gene Protein
 Estrogen only Stretch only Stretch and
   (E) (S) estrogen (E + S)
Cell Proliferation
 TaCC1 Transforming acidic coiled-coil-containing protein 1 0.79 1.01 0.79
 CdK1 Cyclin-dependent kinase 1 0.71 1.15 0.80
 aTP5a1 aTP synthase subunit alpha, mitochondrial 1.23 0.98 1.23
 CTNNb1 Catenin beta-1 1.24 1.06 1.24
 TxNRd1 Thioredoxin reductase 1, cytoplasmic 1.55 1.18 1.44
 Cell adhesion
 aCTN1 alpha-actinin-1  1.36 1.16 1.33
 iTga3 integrin alpha-3  1.50 1.18 1.43
 CTNNb1 Catenin beta-1 1.24 1.06 1.24
 PaRva alpha-parvin 0.76 0.91 0.72
 TxNRd1 Thioredoxin reductase 1, cytoplasmic 1.55 1.18 1.44
 Structural Molecule activity
 aCTR2 actin-related protein 2 1.29 0.93 1.24
FigURE 1. a heatmap of all proteins identified as significantly different (p < 0.05) with cut-off ratio < 0.82 and > 1.2 against control. 
The proteins were assigned based on ratios shown to be changing from control with up-regulated proteins represented by red colour 
while down-regulated proteins represented by green colour. black shading indicates the highest ratio in up-regulated proteins or the 
lowest ratio for down-regulated proteins
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17β-estradiol is the most potent form of estrogen and 
it has been documented to exert direct protective effects 
on vascular endothelial cells (Heldring et al. 2007). 
The protective effects of estrogen such as vasodilation, 
enhancing nitric oxide production, reduced RoS exposure, 
anti-inflammatory and antioxidant effects, coupled with 
increased mitochondrial efficiency for energy production 
are particularly prominent in premenopausal women 
who are exposed to a physiological level of this hormone 
(duckles & Krause 2007; Razmara et al. 2008; Strehlow et 
al. 2003). However, as women enter menopause, cessation 
of menstruation occurs resulting from the loss of ovarian 
follicular activity (gruber et al. 2002). The protective 
effects gradually decline coupled with increased risk of 
cerebrovascular and cardiovascular disease (Kannel et 
al. 1976). Since hypertension is the main risk factor for 
cerebrovascular disease in post-menopausal women, blood 
vessels of these women are exposed to high hemodynamic 
pressure involving tensile stretch. The 20% stretch was 
chosen as it has been documented to be pathological at 
peripheral arteries and the only established reference for 
the pathological stretch intensity on artery (anwar et al. 
2012).
ENdoTHElial CEll RESPoNSE To 17β-ESTRadiol oNly
Comparisons across three different groups against controls 
showed different protein trends as the proteins abundance 
emerges under specific conditions. For instance, some 
proteins did not show changes in S but were found to 
be up-regulated (trend i, Table 1 & Figure 2) or down-
regulated (trend ii, Table 1 & Figure 2) in E and E + 
S. These findings suggest that these proteins were only 
activated by 17β-estradiol regardless of stretch stimulation. 
For instance, TxNRd1 was upregulated approximately 
1.5 fold in trend i. TxNRd1 is an enzyme that is involved 
in thioredoxin reduction, which is a key protein for the 
antioxidant system in reacting against oxidative stress 
(lu & Holmgren 2014). Cyclic strain had been shown 
to generate increased fluxes of the superoxide anion free 
radical in human umbilical vein endothelial cells (HUvEC) 
and exposure of 17β-estradiol successfully inhibits the 
expression of adhesion molecules, chemokines and down 
regulates RoS production (Wagner 2001). Thus, this may 
indicate that 17β-estradiol exposure contributes to the 
protective effects on HCMEC by increasing antioxidant 
expression to counteract the RoS produced during stretch 
(birukov 2009; Chapman et al. 2005).
ENdoTHElial CEll RESPoNSE To PaTHologiCal 
MECHaNiCal STRETCH oNly
a few sets of proteins were identified as being up-regulated 
(trend iii, Table 1 & Figure 2) or down-regulated (trend 
iv, Table 1 & Figure 2) due to stretch only. For example, 
transcription factor ii b (gTF2b) is a general transcription 
factor which is involved in the formation of the RNa 
polymerase II preinitiation complex and aids in stimulating 
transcription initiation (lewis et al. 2004). Mechanical 
stretch known to activate transcription factors such as 
nuclear factor κb (NF-κb) that is involved in inflammation 
(inoh et al. 2002). Meanwhile for trend iv (Table 1 
& Figure 2), stretch suppressed anti-apoptotic related 
proteins such as 14-3-3 protein epsilon (yWHaE) by 0.8 
fold. yWHaE has been found to inhibit pro-apoptotic bad 
from activating apoptosis. This supports the concept that 
pathological stretch is potentially responsible for apoptosis 
as the down-regulation of these proteins renders the cell 
increasingly prone to apoptosis during stretch.
NEUTRaliZiNg EFFECTS oF 17β-ESTRadiol oN 
PaTHologiCal MECHaNiCal STRETCH
17β-estradiol combined with stretch showed different 
protein regulation as shown in trend v and vi (Table 1 & 
Figure 2). For these trends, the protein regulation trends 
were either up or downregulated by estrogen or stretch 
exposure respectively and do not show any changes 
in expression during exposure to estrogen and stretch. 
Thus, the neutralization term been used to represent these 
trends. For instance, d-dopachrome decarboxylase (ddT), 
an enzyme involved in melanin synthesis, points to a 
neutralization effect of 17β-estradiol when combined with 
stretch as the proteins were differentially regulated in E and 
S. Currently, there is no literature to support ddT expression 
in relation to estrogen or stretch, thus its function is 
currently not clearly understood. Meanwhile, a similar 
neutralizing effect was also observed for thrombospondin-1 
(THbS1), a known anti-angiogenic protein (lawler 2002). 
Mechanical stretch is known to stimulate angiogenesis and 
down-regulation of THbS1 will not inhibit this process. 
However, exposure of 17β-estradiol and stretch returned 
the expression level to the baseline. interestingly, the 
protein FaM49b was found to be down-regulated in E 
(0.73 fold) whilst up-regulated in S (1.22 fold) (Table 1 & 
Figure 2). The precise function of this protein has yet to 
be elucidated but is associated with immune dysregulation 
(gilli et al. 2011).
HCMECs express estrogen receptors (ER) that consist 
of ERα, ERβ and g protein estrogen receptors across the 
cell membrane, cytoplasm and nucleus (Tu & Jufri 2013). 
genomic (involves gene activation for transcription 
and protein synthesis) or non-genomic signaling (does 
not involve gene activation) will be activated after the 
binding of 17β-estradiol to these receptors that determines 
cellular responses and phenotypic change in response to 
17β-estradiol stimulation (Meyer & barton 2009). gene 
ontology analysis suggest that 17β-estradiol exposure 
stimulates cell proliferation, structural protein activity 
and cell adhesion. Exposure of 17β-estradiol has been 
found to preserve membrane integrity and focal adhesion 
localization of actin (Razandi et al. 2000). in this study, 
we reported that 17β-estradiol was found to upregulate 
aCTR2 expression that builds cross-linked actin networks 
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Trend vii
iPo5, RPN2, aTP5a, CTNNb1, ddx5, aCTR2, SWaP70, 
aCTN1, iSoC1, KRT10, gPi, Pld3, iTga3, TxNRd1, 
aTP5a1, TKT, TaglN
dNM2, CdK1, HNRNPa3, HdlbP, PaRva, TaCC1, 
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biCd2, TM9SF4, PdHa1, aldH1a2, NUP93, SRRM2, 
gTF2b 
STaT1, SHMT2, xRCC6, dyNC1H1, yWHaE, aNP32b, 
CS, RaN 






































FigURE 2. The proteins were classified into several trends against control. Trend i: protein upregulated in E and E + S; trend ii: 
proteins downregulated in E and E + S; trend iii: proteins upregulated in S and E + S; trend iv: proteins downregulated in S and  
E + S; trend v: protein downregulated in E and upregulated in S, trend vi: proteins upregulated in E and downregulated in S; trend 
vii: proteins downregulated in E, upregulated in S and downregulated in E + S. 
which contributes to stress fibers formation (Hotulainen & 
lappalainen 2006). The alignment of fibers at a particular 
angle can prevent the cell tension that the cell is subjected 
to during deformation (Takemasa et al. 1998). in addition, 
this study suggests that 17β-estradiol also seems to 
promote cell-to-cell adhesion by up-regulation of proteins 
appearing to be compromised during pathological stretch. 
17β-estradiol up-regulated alpha actinin-1 (aCTN1) 
and catenin beta-1 (CTNNb1) that are tightly regulated 
with cadherin that serves to link these proteins to the 
cytoskeleton (Knudsen et al. 1995). However, the cells 
did not significantly change expression of these proteins 
when they were subjected to stretch. This may indicate that 
chronic pathological stretch has the capacity to compromise 
cell-cell adhesion integrity. 
apolipoprotein E (aPoE; Table 1) was found to be the 
most upregulated and has largest change of fold in E and 
E + S groups. aPoE is a type of lipid transport protein to 
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remove excess cholesterol from the blood and has been 
documented to provide protection similar to estrogen as it 
has antioxidant and anti-inflammatory effects (Horsburgh 
et al. 2002). The 17β-estradiol has been proven to 
upregulate aPoE at transcriptional and posttranscriptional 
level and this study recapitulates this finding at proteome 
level (Srivastava et al. 1997; Stone et al. 1997). in addition, 
heme oxygenase (HMox1) was shown to have the largest 
changes after aPoE in all groups. HMox1 is a known 
cytoprotective stress-response enzyme, that plays a critical 
role in the prevention of vascular inflammation and has 
protective effects against atherogenesis (Marcantoni et al. 
2012a). it is normally expressed at low levels in most tissue, 
but different stimuli (e.g., oxidative stress) will increase 
the expression (araujo et al. 2012). indeed, a previous 
study demonstrated that 17β-estradiol exposure was found 
to increase HMox1 level in HUvECs (Marcantoni et al. 
2012b). in this study, the upregulated of HMox1 may be 
due to concurrent stimuli of tensile stretch and the 17β 
-estradiol exposures.
CoNClUSioN
This study suggests that 17β-estradiol can alter HCMEC 
proteome during pathological stretching, as it can change 
the human proteome expression, when compared to 
pathological stretching only. Further investigation of these 
proteins may reveal additional functions of 17β-estradiol 
in relation to vascular endothelial cells abnormality.
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